Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor –neutralizing therapy in patients with inflammatory bowel disease

Nature Medicine 23, 579 (2017).
doi:10.1038/nm.4307

Authors: Nathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, Samuel J Bullers, Bryan Linggi, Sofia Buonocore, Margherita Coccia, Dieter Görtz, Sébastien This, Krista Stockenhuber, Johanna Pott, Matthias Friedrich, Grigory Ryzhakov, Frédéric Baribaud, Carrie Brodmerkel, Constanze Cieluch, Nahid Rahman, Gerhard Müller-Newen, Raymond J Owens, Anja A Kühl, Kevin J Maloy, Scott E Plevy, Carolina Arancibia, Adam Bailey, Ellie Barnes, Beth Bird-Lieberman, Oliver Brain, Barbara Braden, Jane Collier, James East, Lucy Howarth, Satish Keshav, Paul Klenerman, Simon Leedham, Rebecca Palmer, Fiona Powrie, Astor Rodrigues, Alison Simmons, Peter Sullivan, Simon P L Travis, Holm Uhlig, Satish Keshav, Simon P L Travis & Fiona Powrie

Source: Nature Medicine - April 3, 2017 Category: Journals (General) Authors: Nathaniel R West Ahmed N Hegazy Benjamin M J Owens Samuel J Bullers Bryan Linggi Sofia Buonocore Margherita Coccia Dieter G örtz S ébastien This Krista Stockenhuber Johanna Pott Matthias Friedrich Grigory Ryzhakov Fr édéric Baribaud Carrie Brodmerkel Tags: Article Source Type: research